Has Dana Delaski, NP received payments from drug or device companies?

Yes. Drug and device makers reported $158,131 in general payments to Dana Delaski, NP across 854 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dana Delaski, NP did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dana Delaski, NP come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dana Delaski, NP

Family · Jackson, MSNPI 1467753772

Payments from drug & device makers

$158,131in general payments, 2019–2025

Across 854 payments — averaging $185.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Incyte Corporation$144K
Takeda Pharmaceuticals U.S.A., Inc.$2K
AstraZeneca$987
Vertex$932
Bristol Myers Squibb$766
Novartis$560
plus $8K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Incyte Corporation	357	$144,456
Takeda Pharmaceuticals U.S.A., Inc.	22	$1,862
AstraZeneca(2 entities)	30	$987
Vertex	1	$932
Bristol Myers Squibb	30	$766
Novartis	33	$560
Sanofi	29	$550
Beigene USA, Inc.	12	$475
Johnson & Johnson(2 entities)	26	$444
Genentech USA, Inc.	17	$388
E.r. Squibb & Sons, L.L.C.	7	$374
Merck	17	$353
AbbVie	17	$327
Pharmacosmos Therapeutics Inc.	7	$298
Rigel Pharmaceuticals, Inc.	12	$292
Astellas Pharma US Inc	13	$286
Pfizer	15	$265
Gilead(2 entities)	10	$257
Ipsen Biopharmaceuticals, Inc	8	$231
Janssen Scientific Affairs, LLC	2	$230
Pharmacyclics LLC, An Abbvie Company	5	$227
Amgen	15	$208
Blueprint Medicines Corporation	8	$204
GSK	8	$181
Emmaus Medical, Inc.	10	$177
Karyopharm Therapeutics Inc.	9	$166
Sanofi-aventis U.S. LLC	8	$161
Seagen Inc.	10	$155
Daiichi Sankyo Inc.	8	$149
Bayer	7	$147
Adaptive Biotechnologies Corporation	6	$132
Alnylam Pharmaceuticals Inc.	8	$128
Puma Biotechnology, Inc.	3	$116
Immunocore Limited	4	$108
Stemline Therapeutics Inc.	5	$104
Pharmaessentia USA Corporation	5	$104
Taiho Oncology, Inc.	4	$96
Regeneron Healthcare Solutions, Inc.	4	$96
EMD Serono, Inc.	6	$93
Sobi, Inc	4	$90
Morphosys, US Inc.	4	$64
Genentech, Inc.	1	$62
Servier Pharmaceuticals LLC	4	$57
ADC Therapeutics America, Inc.	3	$57
Beone Medicines USA, Inc.	3	$53
Legend Biotech USA Inc.	2	$48
Novo Nordisk	2	$46
Jazz Pharmaceuticals Inc.	2	$44
Acceleron Pharma, Inc.	3	$41
Sanofi US Services Inc.	2	$40
AVEO Pharmaceuticals, Inc.	2	$39
Myovant Sciences Inc.	2	$37
Array Biopharma Inc	2	$32
Bard Peripheral Vascular, Inc.	2	$31
Eisai Inc.	2	$31
Boehringer Ingelheim	2	$30
Geron Corporation	1	$25
Genmab U.S., Inc.	1	$22
G1 Therapeutics, Inc.	1	$21
Recordati_rare_diseases_inc.	1	$21

How this compares

$158,131 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi →

Medicare billing

Part B allowed, 2024

$22,925

Medicare patients

149

Services billed

318

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Jackson

Gina BurgeJackson$237K
Christy DavisJackson$208K
Kristin CarrollJackson$158K
Leondrea CollinsJackson$28K
Elizabeth WilliamsJackson$18K
Anna WalleyJackson$17K
Teresa SpencerJackson$16K
Catherine PageJackson$14K
Mollie DotyJackson$12K
Marty GebhartJackson$12K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →